What is NDC 0187-0146?

0187-0146 is the product NDC for Vaseretic, Enalapril maleate 10 mg/1; Hydrochlorothiazide 25 mg/1 tablet, listed with the FDA by Bausch Health US, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Vaseretic (Enalapril maleate and hydrochlorothiazide).

What is the active ingredient?

Enalapril maleate, Hydrochlorothiazide.

Bausch Health US, LLC, NDC labeler code 0187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vaseretic?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Vaseretic NDC 0187-0146 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0187-0146Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00187-0146Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0187-0146-01	0018701460100187014601	100 TABLET in 1 BOTTLE (0187-0146-01)Marketed from Oct 31, 1986

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vaseretic
Generic name (nonproprietary): enalapril maleate and hydrochlorothiazide
Active ingredients: Enalapril maleate — 10 mg/1Hydrochlorothiazide — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bausch Health US, LLCNDC labeler code 0187
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 019221
Marketing start: Oct 31, 1986
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Decreased Blood Pressure (Physiologic effect)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 0187-0146_b97cbaf1-3abe-4f23-b2a0-4ff43f8bf5cbSPL ID b97cbaf1-3abe-4f23-b2a0-4ff43f8bf5cbSPL set ID bf3007e2-8fcc-48de-8fd5-55e95033d62fRxCUI 858828, 858830UNII 9O25354EPJ, 0J48LPH2THUPC 0301870146011
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400187014601 followed by a unit qualifier and the quantity

Package 00187-0146-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 31, 2020. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE VASERETIC is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial treatment (see DOSAGE AND ADMINISTRATION ). In using VASERETIC, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that enalapril does not have a similar risk (see WARNINGS ). In considering use of VASERETIC, it should be noted that black patients receiving ACE inhibitors have been reported to have a higher incidence of angioedema compared to non-blac…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0187-0146

What is NDC 0187-0146?: 0187-0146 is the product NDC for Vaseretic, Enalapril maleate 10 mg/1; Hydrochlorothiazide 25 mg/1 tablet, listed with the FDA by Bausch Health US, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vaseretic (Enalapril maleate and hydrochlorothiazide).
What is the active ingredient?: Enalapril maleate, Hydrochlorothiazide.
Who is the labeler?: Bausch Health US, LLC, NDC labeler code 0187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vaseretic?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.